Langdon Miller
21Patents
5h-index
32Co-inventors
69Inventor score
Filing activity: Nov 29, 1999 → May 5, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8076352B2 | Administration of carboline derivatives useful in the treatment of cancer and other diseases | Human Necessities | 23 | Active |
| US8716321B2 | Methods for dosing an orally active 1,2,4-oxadiazole | Human Necessities | 23 | Active |
| US6395708B1 | Method for preventing diarrhea | Human Necessities | 10 | Expired |
| US9226919B2 | Methods for dosing an orally active 1,2,4-oxadiazole | Human Necessities | 7 | Active |
| US8703726B2 | Methods for treating prostate conditions | Human Necessities | 6 | Active |
| US9474743B2 | Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease | Human Necessities | 5 | Active |
| US9289398B2 | Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith | Human Necessities | 5 | Active |
| US9522137B2 | Methods for dosing an orally active 1,2,4-Oxadiazole for nonsense mutation suppression therapy | Human Necessities | 5 | Active |
| US8697662B2 | Methods for treating Kaposi sarcoma | Human Necessities | 5 | Active |
| US9351964B2 | Methods for treating cancer and non-neoplastic conditions | Emerging Cross-Sectional Technologies | 5 | Active |
| US9877952B2 | Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy | Human Necessities | 4 | Active |
| US9737513B2 | Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy | Human Necessities | 4 | Active |
| US10034863B2 | Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease | Human Necessities | 3 | Active |
| US10172836B2 | Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation supression therapy | Human Necessities | 2 | Active |
| US6159935A | Method for preventing diarrhea | Human Necessities | 1 | Expired |
| US9492449B2 | Therapies for hematologic malignancies | Human Necessities | 1 | Active |
| US10285980B2 | Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease | Human Necessities | 1 | Active |
| US11497736B2 | Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease | Human Necessities | 0 | Active |
| US10675272B2 | Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease | Human Necessities | 0 | Active |
| US10849885B2 | Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy | Human Necessities | 0 | Active |
| US10154998B2 | Therapies for hematologic malignancies | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.